HONDUR, A. M. Et Al. 2016. Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.3 , 764-768.

HONDUR, A. M., Cubuk, M. O., Ozen Tunay, Z., ATALAY, H. T., Ozdemir, O., Petricli, I. S., ... GÜRELİK, İ. G.(2016). Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.3, 764-768.

HONDUR, AHMET Et Al. "Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.3, 764-768, 2016

HONDUR, AHMET M. Et Al. "Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.3, pp.764-768, 2016

HONDUR, A. M. Et Al. (2016) . "Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.3, pp.764-768.

@article{article, author={AHMET MURAD HONDUR Et Al. }, title={Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2016, pages={764-768} }